Literature DB >> 24534121

Medication burden in bipolar disorder: a chart review of patients at psychiatric hospital admission.

Lauren M Weinstock1, Brandon A Gaudiano2, Gary Epstein-Lubow2, Katherine Tezanos2, Cintly E Celis-Dehoyos2, Ivan W Miller2.   

Abstract

Individuals with bipolar disorder (BD) often receive complex polypharmacy regimens as part of treatment, yet few studies have sought to evaluate patient characteristics associated with this high medication burden. This retrospective chart review study examined rates of complex polypharmacy (i.e., ≥4 psychotropic medications), patterns of psychotropic medication use, and their demographic and clinical correlates in a naturalistic sample of adults with bipolar I disorder (BDI; N=230) presenting for psychiatric hospital admission. Using a computer algorithm, a hospital administrator extracted relevant demographic, clinical, and community treatment information for analysis. Patients reported taking an average of 3.31 (S.D.=1.46) psychotropic medications, and 5.94 (S.D.=3.78) total medications at intake. Overall, 82 (36%) met criteria for complex polypharmacy. Those receiving complex polypharmacy were significantly more likely to be female, to be depressed, to have a comorbid anxiety disorder, and to have a history of suicide attempt. Women were significantly more likely than men to be prescribed antidepressants, benzodiazepines, and stimulants, even after controlling for mood episode polarity. Study data highlight the high medication burden experienced by patients with BD, especially those who are acutely symptomatic. Data also highlight the particularly high medication burden experienced by women with BD; a burden not fully accounted for by depression.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Antidepressants; Benzodiazepines; Bipolar depression; Demography; Mood stabilizers; Polypharmacy; Psychopharmacology

Mesh:

Substances:

Year:  2014        PMID: 24534121      PMCID: PMC3968952          DOI: 10.1016/j.psychres.2014.01.038

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  39 in total

1.  The increasing medical burden in bipolar disorder.

Authors:  David J Kupfer
Journal:  JAMA       Date:  2005-05-25       Impact factor: 56.272

Review 2.  Polypharmacy in bipolar I disorder.

Authors:  D A Solomon; G I Keitner; C E Ryan; I W Miller
Journal:  Psychopharmacol Bull       Date:  1996

3.  A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder.

Authors:  Lewis L Judd; Hagop S Akiskal; Pamela J Schettler; William Coryell; Jean Endicott; Jack D Maser; David A Solomon; Andrew C Leon; Martin B Keller
Journal:  Arch Gen Psychiatry       Date:  2003-03

4.  DSM-IV depressive symptom expression among individuals with a history of hypomania: a comparison to those with or without a history of mania.

Authors:  Lauren M Weinstock; David Strong; Lisa A Uebelacker; Ivan W Miller
Journal:  J Psychiatr Res       Date:  2010-04-15       Impact factor: 4.791

5.  Does provider adherence to a treatment guideline change clinical outcomes for patients with bipolar disorder? Results from the Texas Medication Algorithm Project.

Authors:  Ellen B Dennehy; Trisha Suppes; A John Rush; Alexander L Miller; Madhukar H Trivedi; M Lynn Crismon; Thomas J Carmody; T Michael Kashner
Journal:  Psychol Med       Date:  2005-09-29       Impact factor: 7.723

6.  Nosology, diagnostic challenges, and unmet needs in managing bipolar disorder.

Authors:  Terence A Ketter
Journal:  J Clin Psychiatry       Date:  2010-10       Impact factor: 4.384

Review 7.  Polypharmacy and bipolar disorder: what's personality got to do with it?

Authors:  G S Sachs; A T Peters; L Sylvia; H Grunze
Journal:  Int J Neuropsychopharmacol       Date:  2013-09-26       Impact factor: 5.176

8.  Morbidity in 258 bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH life chart method.

Authors:  Robert M Post; Kirk D Denicoff; Gabriele S Leverich; Lori L Altshuler; Mark A Frye; Trisha M Suppes; A John Rush; Paul E Keck; Susan L McElroy; David A Luckenbaugh; Chad Pollio; Ralph Kupka; Willem A Nolen
Journal:  J Clin Psychiatry       Date:  2003-06       Impact factor: 4.384

9.  Improving treatment adherence in bipolar disorder: a review of current psychosocial treatment efficacy and recommendations for future treatment development.

Authors:  Brandon A Gaudiano; Lauren M Weinstock; Ivan W Miller
Journal:  Behav Modif       Date:  2008-05

10.  Is antipsychotic polypharmacy associated with metabolic syndrome even after adjustment for lifestyle effects?: a cross-sectional study.

Authors:  Fuminari Misawa; Keiko Shimizu; Yasuo Fujii; Ryouji Miyata; Fumio Koshiishi; Mihoko Kobayashi; Hirokazu Shida; Yoshiyo Oguchi; Yasuyuki Okumura; Hiroto Ito; Mami Kayama; Haruo Kashima
Journal:  BMC Psychiatry       Date:  2011-07-26       Impact factor: 3.630

View more
  22 in total

1.  Identifying clinical net benefit of psychotropic medication use with latent variable techniques: Evidence from Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).

Authors:  Natalie Bareis; Juan Lu; Cynthia K Kirkwood; Susan G Kornstein; Elwin Wu; Briana Mezuk
Journal:  J Affect Disord       Date:  2018-05-29       Impact factor: 4.839

Review 2.  Epidemiology, neurobiology and pharmacological interventions related to suicide deaths and suicide attempts in bipolar disorder: Part I of a report of the International Society for Bipolar Disorders Task Force on Suicide in Bipolar Disorder.

Authors:  Ayal Schaffer; Erkki T Isometsä; Leonardo Tondo; Doris H Moreno; Mark Sinyor; Lars Vedel Kessing; Gustavo Turecki; Abraham Weizman; Jean-Michel Azorin; Kyooseob Ha; Catherine Reis; Frederick Cassidy; Tina Goldstein; Zoltán Rihmer; Annette Beautrais; Yuan-Hwa Chou; Nancy Diazgranados; Anthony J Levitt; Carlos A Zarate; Lakshmi Yatham
Journal:  Aust N Z J Psychiatry       Date:  2015-07-16       Impact factor: 5.744

3.  Complex polypharmacy in bipolar disorder: Side effect burden, adherence, and response predictors.

Authors:  Vicki C Fung; Lindsay N Overhage; Louisa G Sylvia; Noreen A Reilly-Harrington; Masoud Kamali; Keming Gao; Richard C Shelton; Terence A Ketter; William V Bobo; Michael E Thase; Joseph R Calabrese; Mauricio Tohen; Thilo Deckersbach; Andrew A Nierenberg
Journal:  J Affect Disord       Date:  2019-07-02       Impact factor: 4.839

4.  Dosing patterns and medication adherence in bipolar disorder patients treated with lurasidone: a US retrospective claims database analysis.

Authors:  Martha Sajatovic; Daisy Ng-Mak; Caitlyn T Solem; Fang-Ju Lin; Krithika Rajagopalan; Antony Loebel
Journal:  Ther Adv Psychopharmacol       Date:  2016-10-13

5.  Adjunctive psychosocial intervention following Hospital discharge for Patients with bipolar disorder and comorbid substance use: A pilot randomized controlled trial.

Authors:  Susan J Wenze; Brandon A Gaudiano; Lauren M Weinstock; Katherine M Tezanos; Ivan W Miller
Journal:  Psychiatry Res       Date:  2015-06-15       Impact factor: 3.222

6.  Valued Living and Its Relationship to Medication Adherence in Patients with Bipolar and Comorbid Substance Use Disorders.

Authors:  Brandon A Gaudiano; Susan J Wenze; Lauren M Weinstock; Katherine M Tezanos; Ivan W Miller
Journal:  J Nerv Ment Dis       Date:  2017-03       Impact factor: 2.254

7.  Demographic and clinical characteristics associated with comorbid cannabis use disorders (CUDs) in hospitalized patients with bipolar I disorder.

Authors:  Lauren M Weinstock; Brandon A Gaudiano; Susan J Wenze; Gary Epstein-Lubow; Ivan W Miller
Journal:  Compr Psychiatry       Date:  2015-10-23       Impact factor: 3.735

Review 8.  Complex Combination Pharmacotherapy for Bipolar Disorder: Knowing When Less Is More or More Is Better.

Authors:  Joseph F Goldberg
Journal:  Focus (Am Psychiatr Publ)       Date:  2019-07-16

9.  Predictors of 30-day rehospitalization in a sample of hospitalized patients with Bipolar I disorder.

Authors:  Melanie L Bozzay; Brandon A Gaudiano; Sarah Arias; Gary Epstein-Lubow; Ivan W Miller; Lauren M Weinstock
Journal:  Psychiatry Res       Date:  2019-09-07       Impact factor: 3.222

10.  Sequential Multiple Assignment Randomized Treatment (SMART) for Bipolar Disorder at Any Phase of Illness and at least Mild Symptom Severity.

Authors:  Keming Gao; Jodi G Arnold; Thomas J Prihoda; Marlon Quinones; Vivek Singh; Martha Schinagle; Carla Conroy; Nicole D'Arcangelo; Yuanhan Bai; Joseph R Calabrese; Charles L Bowden
Journal:  Psychopharmacol Bull       Date:  2020-05-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.